VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GLRE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GLREGreenlight Capital Re, Ltd.
$16.42$545M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksGLREQuarterly Financials

Greenlight Capital Re, Ltd. (GLRE) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Greenlight Capital Re, Ltd. (GLRE) quarterly income statement — complete revenue, gross profit & net income history

GLRE Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue189.66M177.93M160.47M178.38M179.56M136.21M168.16M170.53M168.03M154.58M168.78M156.91M158.12M115.14M118.2M109.54M128.95M142.1M145.49M136.52M
Revenue Growth %5.62%30.63%-4.57%4.6%6.86%-11.88%-0.36%8.68%6.26%34.25%42.79%43.24%22.62%-18.97%-18.75%-19.76%-13.65%8.53%23.84%20.57%
Medical Costs & Claims0-40.64M135.56M146.93M169.75M161.29M139.33M152.49M150.94M118.11M143.78M128.8M00131.38M97.16M130.35M118.8M145.45M124.59M
Medical Cost Ratio %0%-22.84%84.47%82.37%94.53%118.41%82.85%89.42%89.83%76.41%85.19%82.08%0%0%111.15%88.69%101.09%83.61%99.97%91.26%
Gross Profit0218.57M24.92M31.45M9.81M-25.08M28.84M18.05M17.09M36.47M25M28.11M158.12M115.14M-13.18M12.38M-1.4M23.3M37K11.93M
Gross Margin %0%122.84%15.53%17.63%5.47%-18.41%17.15%10.58%10.17%23.59%14.81%17.92%100%100%-11.15%11.31%-1.09%16.39%0.03%8.74%
Gross Profit Growth %-100%971.41%-13.58%74.3%-42.59%-168.77%15.35%-35.8%-89.19%-68.32%289.7%126.99%11394.57%394.24%-35716.22%3.77%-107.68%73.74%-98.46%94.46%
Operating Expenses0167.96M28.8M30.78M-21.09M3.26M-7.12M9.63M-10.44M18.88M11.49M-21.78M158.12M115.14M6.11M-2.41M4.34M-1.02M13.89M11.31M
OpEx / Revenue %0%94.4%17.95%17.26%-11.75%2.4%-4.24%5.65%-6.22%12.21%6.81%-13.88%100%100%5.17%-2.2%3.37%-0.72%9.55%8.28%
Depreciation & Amortization00000000000744K-803K691K-933K1.17M-845K1.58M-422K1.57M
Combined Ratio %0%71.56%102.42%99.62%82.79%120.81%78.62%95.07%83.61%88.62%92%68.21%100%100%116.32%86.49%104.45%82.89%109.52%99.54%
Operating Income050.61M-3.88M675K30.91M-28.35M35.96M8.41M27.54M17.59M13.51M49.89M00-19.29M14.8M-5.74M24.32M-13.85M627K
Operating Margin %0%28.44%-2.42%0.38%17.21%-20.81%21.38%4.93%16.39%11.38%8%31.79%0%0%-16.32%13.51%-4.45%17.11%-9.52%0.46%
Operating Income Growth %-100%278.53%-110.79%-91.98%12.24%-261.1%166.25%-83.14%--170.03%237.15%100%-100%-39.21%2259.97%-156.12%-42.12%-734.59%1095.24%
EBITDA050.99M-2.35M1.94M32.52M-27.13M38.35M11.86M29.66M22M15.24M50.63M6.05M36.58M-20.22M15.96M-6.59M25.9M-14.28M2.2M
EBITDA Margin %0%28.66%-1.47%1.09%18.11%-19.92%22.81%6.95%17.65%14.23%9.03%32.27%3.82%31.77%-17.1%14.57%-5.11%18.22%-9.81%1.61%
Interest Expense32K382K1.52M1.27M1.61M1.22M2.4M3.45M2.13M4.41M1.74M979K908K1.13M7.24M1.36M1.19M13.23M1.62M1.56M
Non-Operating Income0-382K-1.52M-1.27M-1.61M-1.22M-2.4M-3.45M-2.13M-4.41M-1.74M-979K-6.85M-35.89M-7.24M-1.36M-1.19M-13.23M-1.62M-1.56M
Pretax Income35.87M50.61M-3.88M675K30.91M-28.35M35.96M8.41M27.54M17.59M13.51M49.89M5.94M34.76M-19.29M14.8M-5.74M24.32M-13.85M627K
Pretax Margin %18.91%28.44%-2.42%0.38%17.21%-20.81%21.38%4.93%16.39%11.38%8%31.79%3.76%30.19%-16.32%13.51%-4.45%17.11%-9.52%0.46%
Income Tax-115K1.32M526K346K1.28M-928K723K435K519K-11K29K28K54K7K-816K9K-16K13K0-1K
Effective Tax Rate %-0.32%2.62%-13.56%51.26%4.15%3.27%2.01%5.17%1.88%-0.06%0.21%0.06%0.91%0.02%4.23%0.06%0.28%0.05%0%-0.16%
Net Income35.75M49.28M-4.41M329K29.63M-27.42M35.24M7.98M27.02M17.61M13.48M49.86M5.89M34.75M-18.47M14.79M-5.73M24.3M-13.85M628K
Net Margin %18.85%27.7%-2.74%0.18%16.5%-20.13%20.95%4.68%16.08%11.39%7.99%31.78%3.72%30.18%-15.62%13.5%-4.44%17.1%-9.52%0.46%
Net Income Growth %20.67%279.74%-112.5%-95.88%9.65%-255.73%161.46%-84%358.96%-49.34%172.97%237.17%202.79%42.98%-33.32%2254.78%-188.12%-42.16%-734.59%1096.83%
EPS (Diluted)1.051.43-0.130.010.86-0.811.010.230.780.500.391.300.170.91-0.560.37-0.170.71-0.420.02
EPS Growth %22.09%276.54%-112.87%-95.83%10.26%-262%158.97%-82.31%358.82%-45.05%169.64%251.35%200%28.17%-33.33%1750%-189.47%-40.83%-800%-
EPS (Basic)1.061.46-0.130.010.87-0.811.030.230.790.500.401.460.181.01-0.560.37-0.170.72-0.420.02
Diluted Shares Outstanding34.17M34.5M33.76M34.42M34.42M33.85M34.81M34.7M34.65M35.34M34.8M38.27M38.23M38.19M33.13M40.11M32.93M34.23M32.93M34.82M